Stifel Financial
AZN icon

Stifel Financial’s AstraZeneca AZN Stock Holding History

Stifel Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$7K – 2308
2014
Q4 		$7K Hold
100
– – ﹤0.01% 2303
2014
Q3 		$7K Buy
+100
New +$7.32K ﹤0.01% 2210

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Stifel Financial's AZN Position: Q1 2026 in Review

Stifel Financial increased its AstraZeneca (AZN) stake by 6.2% in Q1 2026, buying an estimated $7.71M and bringing the position to 684,404 shares worth $135M. The position accounts for 0.12% of the portfolio, ranked #187.

Stifel Financial first reported a position in AZN in Q1 2014 and has held it in 49 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Stifel Financial held 684,404 shares of AstraZeneca worth $135M as of Q1 2026.
  • Stifel Financial bought 39,976 AstraZeneca shares in Q1 2026, an estimated $7.71M.
  • AstraZeneca made up 0.12% of Stifel Financial's portfolio in Q1 2026, its #187 holding.
  • Stifel Financial first reported a position in AstraZeneca in Q1 2014 and has held it in 49 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.